Treatment of pityriasis rubra pilaris type I: a systematic review

被引:0
作者
Carina Engelmann
Peter Elsner
Diana Miguel
机构
[1] University Hospital,Department of Dermatology
来源
European Journal of Dermatology | 2019年 / 29卷
关键词
biologicals; pityriasis rubra pilaris type I; retinoids; treatment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:524 / 537
页数:13
相关论文
共 541 条
[21]  
Haeusermann P(1997)The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis J Am Acad Dermatol 37 S69-300
[22]  
Ross NA(1994)Topical treatment of pityriasis rubra pilaris with calcipotriol Br J Dermatol 130 675-3
[23]  
Chung HJ(2002)Pityriasis rubra pilaris in association with polyarthritis Dermatology 205 298-8
[24]  
Li Q(2009)Pityriasis rubra pilaris sensitive to narrow band-ultraviolet B light therapy J Drugs Dermatol 8 270-9
[25]  
Andrews JP(2010)Type I pityriasis rubra pilaris: upregulation of tumor necrosis factor alpha and response to adalimumab therapy J Cutan Med Surg 14 185-4
[26]  
Keller MS(2007)Clinical improvement of pityriasis rubra pilaris with combination etanercept and acitretin therapy Arch Dermatol 143 1597-9
[27]  
Uitto J(2005)The anti-psoriatic drug anthralin accumulates in keratinocyte mitochondria, dissipates mitochondrial membrane potential, and induces apoptosis through a pathway dependent on respiratory competent mitochondria FASEB J 19 1012-60
[28]  
Mease PJ(1996)Anti-psoriatic drug anthralin activates transcription factor NF-kappa B in murine keratinocytes J Immunol 156 4514-31
[29]  
Wallace AD(2014)Anthralin/dithranol in dermatology Int J Dermatol 53 e449-26
[30]  
Cidlowski JA(2015)Alitretinoin (9-cis retinoic acid) is effective against pityriasis rubra pilaris: a retrospective clinical study Acta Derm Venereol 95 329-8